New GLP-1 for Alcohol Addiction and IBS, Instagram's AI Fake Crackdown + 5 New Health Tools

Podcast: The Chalene Show | Pop Culture, Women's Health, & Fitness · Chalene Johnson

Opublikowano: 2026-09-02

Eli Lilly is testing a new GLP-1 called brenipatide in phase three trials, and weight loss isn't even the main focus, researchers are watching it for alcohol use disorder, opioid addiction, bipolar disorder, and IBS. Chalene Johnson also breaks down a new Yale University study on why the hunger hormones ghrelin and leptin roar back the moment someone stops taking a GLP-1. Then Chalene calls out an Instagram account called Baddie Bethany (also posting as Baddie Betty on Facebook), nearly a million followers and Instagram is rolling out a brand new AI content label. She also flags...